Changes in vitreous VEGF, bFGF and fibrosis in proliferative diabetic retinopathy after in

Changes in vitreous VEGF, bFGF and fibrosis in proliferative diabetic retinopathy after intravitreal

bevacizumab

Jiu-Ke Li; Fang Wei; Xiao-Hong Jin; Yuan-Min Dai; Hu-Shan Cui; Yu-Min Li

【期刊名称】《《国际眼科杂志：英文版》》 【年(卷),期】2015(000)006

【摘要】AIM: To evaluate the relationship between intravitreal bevacizumab(IVB) treatment and the levels of vitreous vascular endothelial growth factor(VEGF), basic fibroblast growth factor(b FGF) and vitreous-retina surface fibrosis in patients with proliferative diabetic retinopathy(PDR).·METHODS: This study was a prospective, open-label,controlled, randomized clinical trial. Sixty-eight eyes of PDR patients(n =53) and macular hole patients(n =15)were enrolled in this study. Thirty-four eyes of the PDR patients received IVB before vitrectomy. Twenty-three of the 34 PDR patients received IVB treatment 5d before vitrectomy(subgroup a), and 11 of the 34 PDR patients received IVB treatment greater than 2wk prior to vitrectomy(subgroup b). Nineteen of the PDR patients did not receive IVB treatment at any time prior to vitrectomy. The levels of b FGF and VEGF in vitreous samples were measured using enzyme-linked immunosorbent assay(ELISA) and the degree of vitreoretinal fibrosis was characterized using clinical data and data obtained intra-operatively.·RESULTS: In PDR

patients, VEGF and b FGF levels were significantly increased compared to non-PDR(control) subject’s eyes(P <0.01). In PDR patients,vitreous VEGF levels were significantly decreased following IVB treatment compared to PDR patients that did not receive IVB treatment(P <0.01). The degree of vitreoretinal fibrosis was significantly increased in subgroup b compared to subgroup a(P <0.05) and to patients that did not receive IVB(P <0.05). Vitreous b FGF levels were significantly greater in subgroup b than subgroup a(P <0.01) or in patients who did not receive IVB treatment(P <0.05). A Spearman’s rank correlationtest indicated that higher levels of vitreous b FGF, but not VEGF, correlated with the degree of vitreoretinal fibrosis.·CONCLUSION: We found that b FGF levels increase in PDR patient’s vitreous after IVB treatment longer than two weeks prior to vitrectomy and correlated with the degree of fibrosis after IVB treatment. These findings suggest vitreous fibrosis is increased in PDR patients after IVB treatment may be due to increased levels of b FGF.

【总页数】5页(P.1202-1206) 【关键词】

【作者】Jiu-Ke Li; Fang Wei; Xiao-Hong Jin; Yuan-Min Dai; Hu-Shan Cui; Yu-Min Li

【作者单位】Department of Ophthalmology Sir Run Run Shaw Hospital School of Medicine Zhejiang University

【正文语种】中文 【中图分类】R587.2 【文献来源】

https://www.zhangqiaokeyan.com/academic-journal-cn_international-journal-ophthalmology_thesis/0201276097341.html 【相关文献】

1.Diabetic retinopathy:VEGF, bFGF and retinal vascular pathology [J], 宋鄂; 董宇; 韩丽娜; 隋东明; 徐琪; 王心蕊; 吴稼祥

2.Changes of Expressions of VEGF, bFGF, and Angiogenesis, and Effect of Benazepril, bFGF on Angiogenesis in Acute Myocardial Infarction Model of the Rabbits [J], DAN-YANG LI; KUI ZHAO; JUN-FU ZHOU; PENG CHEN; WEI LI 3.Electroacupuncture

combined

with

intermittent

pneumatic

compression therapeutic apparatus for diabetic peripheral neuropathy and the effect on HIF-1α and VEGF levels [J], Yuan JIANG; Qiongfen WANG; Chun LI; Rang LI; Lan MEI; Hong ZHANG

4.Correlation of serum ICAM-1 and VEGF levels with microvascular injury in patients with senile diabetic retinopathy [J], Xing-Guang He; Lan-Lan Gong; Cai-Han Xu

5.Change and significance of serum inflammatory factors, vWf, VEGF and adhesion molecules in patients with diabetic nephropathy [J], Fei Wang; Xiang-Yang Gao; Rong Zhang

以上内容为文献基本信息，获取文献全文请下载